Posted on: 12 June, 2019
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer.
Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best analytical facilities in the world.
Professo.....
Read more
Category: World-leading technology, New Treatment